WuXi AppTec Co. Ltd. (WUXAY)
OTC Markets OTCPK: WUXAY
· Real-Time Price · USD
25.55
-0.01 (-0.04%)
At close: Aug 14, 2026, 3:31 PM
WuXi AppTec Co. Ltd. (WUXAY) Stock Price, Analysis & Data
-0.04% (1D)
| Bid | n/a |
| Market Cap | 76.23B |
| Revenue (ttm) | 51.52B |
| Net Income (ttm) | 20.34B |
| Beta | 0.46 |
| EPS (ttm) | 1.09 |
| PE Ratio (ttm) | 23.44 |
| Forward PE | n/a |
| P/B (ttm) | 6.13 |
| P/S (ttm) | 1.48 |
| Earnings Date | n/a |
| Ask | n/a |
| Volume | 1,571 |
| Avg. Volume (20D) | 2,214 |
| Open | 26.04 |
| Previous Close | 25.56 |
| Day's Range | 25.55 - 26.04 |
| 52-Week Range | 12.45 - 26.04 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | $0.31 (1.2%) |
| Ex-Dividend Date | Aug 19, 2026 |
About WUXAY
WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People's Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug...
Industry Diagnostics & Research
Sector Healthcare
IPO Date Aug 15, 2024
Employees 35,584
Stock Exchange OTC Markets OTCPK
Ticker Symbol WUXAY
Website https://www.wuxiapptec.com
Financial Performance
In 2025, WuXi AppTec's revenue was 45.46B, an increase of 15.84% compared to the previous year's 39.24B. Earnings were 19.15B, an increase of 102.65%.
Financial Statements
Page 1 of 2